PROPANC BIOPHARMA, INC. AMENDED AND RESTATED DIRECTOR AGREEMENTDirector Agreement • August 18th, 2021 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 18th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED DIRECTOR AGREEMENT (this “Agreement”) by and between Josef Zelinger (“Director”) and Propanc Biopharma, Inc. (“Company”, and collectively, the “Parties”) is made effective on of August 12, 2021. This Agreement is intended to and hereby amends and restates in its entirety that certain Director Agreement between the Parties entered into as of December 23, 2020 (the “Appointment Date”).
PROPANC BIOPHARMA, INC. DIRECTOR AGREEMENTDirector Agreement • December 30th, 2020 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 30th, 2020 Company Industry JurisdictionThis DIRECTOR AGREEMENT (this “Agreement”) by and between Josef Zelinger (“Director”) and Propanc Biopharma, Inc. (“Company”), is dated and effective as of December 23, 2020 (the “Appointment Date”).